Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants

Open access
Manickam, Kandamurugu, Buchanan, Adam H., Schwartz, Marci L. B., Hallquist, Miranda L. G., Williams, Janet L., Rahm, Alanna Kulchak, Rocha, Heather, Savatt, Juliann M., Evans, Alyson E., Butry, Loren M., Lazzeri, Amanda L., Lindbuchler, D’Andra M., Flansburg, Carroll N., Leeming, Rosemary, Vogel, Victor G., Lebo, Matthew S., Mason-Suares, Heather M., Hoskinson, Derick C., Abul-Husn, Noura S., Dewey, Frederick E., Overton, John D., Reid, Jeffrey G., Baras, Aris, Willard, Huntington F., McCormick, Cara Z., Krishnamurthy, Sarath B., Hartzel, Dustin N., Kost, Korey A., Lavage, Daniel R., Sturm, Amy C., Frisbie, Lauren R., Person, T. Nate, Metpally, Raghu P., Giovanni, Monica A., Lowry, Lacy E., Leader, Joseph B., Ritchie, Marylyn D., Carey, David J., Justice, Anne E., Kirchner, H. Lester, Faucett, W. Andrew, Williams, Marc S., Ledbetter, David H., Murray, Michael F. · 2018 · JAMA Network Open

Abstract

Importance: Detection of disease-associated variants in the BRCA1 and BRCA2 (BRCA1/2) genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives: To identify pathogenic and likely pathogenic (P/LP) BRCA1/2 variants in an unselected research cohort, and to characterize the features associated with P/LP variants. Design, Setting, and Participants: This is a cross-sectional study of adult volunteers (n = 50 726) who underwent exome sequencing at a single health care system (Geisinger Health System, Danville, Pennsylvania) from January 1, 2014, to March 1, 2016. Participants are part of the DiscovEHR cohort and were identified through the Geisinger MyCode Community Health Initiative. They consented to a research protocol that included sequencing and return of actionable test results. Clinical data from electronic health records and clinical visits were correlated with variants. Comparisons were made between those with (cases) and those without (controls) P/LP variants in BRCA1/2. Main Outcomes: Prevalence of P/LP BRCA1/2 variants in cohort, proportion of variant carriers not previously ascertained through clinical testing, and personal and family history of relevant cancers among BRCA1/2 variant carriers and noncarriers. Results: Of the 50 726 health system patients who underwent exome sequencing, 50 459 (99.5%) had no expected pathogenic BRCA1/2 variants and 267 (0.5%) were BRCA1/2 carriers. Of the 267 cases (148 [55.4%] were women and 119 [44.6%] were men with a mean [range] age of 58.9 [23-90] years), 183 (68.5%) received clinically confirmed results in their electronic health record. Among the 267 participants with P/LP BRCA1/2 variants, 219 (82.0%) had no prior clinical testing, 95 (35.6%) had BRCA1 variants, and 172 (64.4%) had BRCA2 variants. Syndromic cancer diagnoses were present in 11 (47.8%) of the 23 deceased BRCA1/2 carriers and in 56 (20.9%) of all 267 BRCA1/2 carriers. Among women, 31 (20.9%) of 148 variant carriers had a personal history of breast cancer, compared with 1554 (5.2%) of 29 880 noncarriers (odds ratio [OR], 5.95; 95% CI, 3.88-9.13; P < .001). Ovarian cancer history was present in 15 (10.1%) of 148 variant carriers and in 195 (0.6%) of 29 880 variant noncarriers (OR, 18.30; 95% CI, 10.48-31.4; P < .001). Among 89 BRCA1/2 carriers without prior testing but with comprehensive personal and family history data, 44 (49.4%) did not meet published guidelines for clinical testing. Conclusions and Relevance: This study found that compared with previous clinical care, exome sequencing-based screening identified 5 times as many individuals with P/LP BRCA1/2 variants. These findings suggest that genomic screening may identify BRCA1/2-associated cancer risk that might otherwise remain undetected within health care systems and may provide opportunities to reduce morbidity and mortality in patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2018.2140

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Manickam, K., Buchanan, A. H., Schwartz, M. L. B., Hallquist, M. L. G., Williams, J. L., Rahm, A. K., Rocha, H., Savatt, J. M., Evans, A. E., Butry, L. M., Lazzeri, A. L., Lindbuchler, D. M., Flansburg, C. N., Leeming, R., Vogel, V. G., Lebo, M. S., Mason-Suares, H. M., Hoskinson, D. C., Abul-Husn, N. S., Dewey, F. E., Overton, J. D., Reid, J. G., Baras, A., Willard, H. F., McCormick, C. Z., Krishnamurthy, S. B., Hartzel, D. N., Kost, K. A., Lavage, D. R., Sturm, A. C., Frisbie, L. R., Person, T. N., Metpally, R. P., Giovanni, M. A., Lowry, L. E., Leader, J. B., Ritchie, M. D., Carey, D. J., Justice, A. E., Kirchner, H. L., Faucett, W. A., Williams, M. S., Ledbetter, D. H., & Murray, M. F.
Venue
JAMA Network Open
Published
2018-09-21
Volume
1
Issue
5
Pages
e182140
ISSN
2574-3805 (ISSN-L)
OpenAlex
W2897424463
Cited by
208
References
6
FWCI
12.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.